• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾细胞癌伴肿瘤栓子逆血流生长:手术复杂和预后不良的指标。

Renal cell carcinoma with tumor thrombus growing against the direction of venous return: an indicator of complicated surgery and poor prognosis.

机构信息

Department of Urology, Peking University Third Hospital, 49 North Garden Road, Haidian, Beijing, 100191, People's Republic of China.

Department of Ultrasound, Peking University Third Hospital, Haidian District, Beijing, 100191, People's Republic of China.

出版信息

BMC Surg. 2021 Dec 28;21(1):443. doi: 10.1186/s12893-021-01448-0.

DOI:10.1186/s12893-021-01448-0
PMID:34963464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8713414/
Abstract

PURPOSE

To explore the effect of tumor thrombus growing against the direction of venous return (GADVR) tumor thrombus on the choice of surgical approach, the impact on the complexity of the surgery and the prognosis.

METHODS

We retrospectively analyzed the clinicopathological data of 213 patients, who underwent surgery in a single center of Peking University Third Hospital between January 2016 and June 2020. For right renal cell carcinoma (RCC) and venous tumor thrombus (VTT), imaging revealed a filling defect in the left renal vein, which was significantly enhanced in enhanced imaging, suggesting that the tumor thrombus grew against the direction of venous return into the left renal vein. For left RCC and VTT, at least one of the left renal vein branches has tumor thrombus. The branches include the left adrenal vein, the left gonadal vein (testicular vein or ovarian vein), and the left ascending lumbar vein. The patients were divided into two groups according to whether they were GADVR tumor thrombus, and we compare the clinicopathological characteristics of GADVR tumor thrombus and non-GADVR tumor thrombus. Univariate and multivariate Cox regression analyses were performed to explore the risk factors that affect the prognosis of patients with RCC and VTT. Kaplan-Meier plots were conducted to evaluate the effect of GADVR on progression-free survival (PFS).

RESULTS

Compared with non-GADVR tumor thrombus, patients with GADVR tumor thrombus had a higher proportion of open surgery (76.2% vs. 52.1%, P = 0.035), a higher proportion of tumor thrombus adhering to the inferior vena cava (IVC) vessel wall (81% vs. 45.8%, P = 0.002), a higher proportion of segmental resection of the IVC vessel wall (61.9% vs. 15.6%, P < 0.001); higher preoperative serum creatinine value (110.0 μmol/L vs. 91.0 μmol/L, P = 0.015), a higher proportion of tumor thrombus combined with bland thrombus (non-tumor thrombus) (57.1% vs. 19.8%, P < 0.001). In terms of surgical complexity, patients with GADVR tumor thrombus had a longer median operation time (379 min vs. 308 min, P = 0.038), more median surgical blood loss (1400 mL vs. 600 mL, P = 0.018), and more postoperative complications (52.4% vs. 30.7%, P = 0.045). Multivariate Cox regression analysis showed that GADVR tumor thrombus, symptoms, postoperative serum creatinine, distant metastasis, sarcomatoid feature, pathological type, lymph node dissection were independent risk factors for PFS. Patients with GADVR tumor thrombus's median survival time was 14.0 months, while patients with non-GADVR tumor thrombus were 32.0 months (P = 0.016). GADVR tumor thrombus is an independent risk factor for PFS in patients with RCC and VTT.

CONCLUSION

GADVR tumor thrombus is a characteristic feature of tumor thrombus, with an incidence of 9.9%. It has a higher proportion of open surgery and higher surgical complexity, which is an independent risk factor for PFS.

摘要

目的

探讨肿瘤栓子沿静脉回流方向生长(GADVR)对手术方式选择、手术复杂性及预后的影响。

方法

我们回顾性分析了 2016 年 1 月至 2020 年 6 月在北京大学第三医院单一中心接受手术的 213 例患者的临床病理资料。对于右肾癌(RCC)和静脉瘤栓(VTT),影像学显示左肾静脉有充盈缺损,增强成像明显增强,提示瘤栓沿静脉回流方向生长进入左肾静脉。对于左 RCC 和 VTT,至少有一支左肾静脉分支有瘤栓。这些分支包括左肾上腺静脉、左性腺静脉(睾丸静脉或卵巢静脉)和左升主动脉静脉。根据是否存在 GADVR 瘤栓,将患者分为两组,并比较 GADVR 瘤栓和非 GADVR 瘤栓的临床病理特征。采用单因素和多因素 Cox 回归分析探讨影响 RCC 和 VTT 患者预后的危险因素。通过 Kaplan-Meier 图评估 GADVR 对无进展生存期(PFS)的影响。

结果

与非 GADVR 瘤栓相比,GADVR 瘤栓患者开放性手术的比例更高(76.2% vs. 52.1%,P = 0.035),瘤栓与下腔静脉(IVC)血管壁黏附的比例更高(81% vs. 45.8%,P = 0.002),IVC 血管壁节段切除的比例更高(61.9% vs. 15.6%,P < 0.001);术前血清肌酐值更高(110.0 μmol/L vs. 91.0 μmol/L,P = 0.015),瘤栓合并软血栓(非瘤栓)的比例更高(57.1% vs. 19.8%,P < 0.001)。在手术复杂性方面,GADVR 瘤栓患者的中位手术时间更长(379 分钟 vs. 308 分钟,P = 0.038),中位手术出血量更多(1400 毫升 vs. 600 毫升,P = 0.018),术后并发症更多(52.4% vs. 30.7%,P = 0.045)。多因素 Cox 回归分析显示,GADVR 瘤栓、症状、术后血清肌酐、远处转移、肉瘤样特征、病理类型、淋巴结清扫是 PFS 的独立危险因素。GADVR 瘤栓患者的中位生存时间为 14.0 个月,而非 GADVR 瘤栓患者为 32.0 个月(P = 0.016)。GADVR 瘤栓是 RCC 和 VTT 患者 PFS 的独立危险因素。

结论

GADVR 瘤栓是一种肿瘤栓子的特征性表现,发生率为 9.9%。它具有更高的开放性手术比例和更高的手术复杂性,是 PFS 的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac3/8713414/e9f0db030654/12893_2021_1448_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac3/8713414/d1f91c60555c/12893_2021_1448_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac3/8713414/7970f61745a9/12893_2021_1448_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac3/8713414/e9f0db030654/12893_2021_1448_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac3/8713414/d1f91c60555c/12893_2021_1448_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac3/8713414/7970f61745a9/12893_2021_1448_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ac3/8713414/e9f0db030654/12893_2021_1448_Fig3_HTML.jpg

相似文献

1
Renal cell carcinoma with tumor thrombus growing against the direction of venous return: an indicator of complicated surgery and poor prognosis.肾细胞癌伴肿瘤栓子逆血流生长:手术复杂和预后不良的指标。
BMC Surg. 2021 Dec 28;21(1):443. doi: 10.1186/s12893-021-01448-0.
2
[Influence of deep invasive tumor thrombus on the surgical treatment and prognosis of patients with non-metastatic renal cell carcinoma complicated with venous tumor thrombus].[深部浸润性肿瘤血栓对非转移性肾细胞癌合并静脉瘤栓患者手术治疗及预后的影响]
Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Aug 18;53(4):665-670. doi: 10.19723/j.issn.1671-167X.2021.04.007.
3
Imaging predictors for assessment of inferior vena cava wall invasion in patients with renal cell carcinoma and inferior vena cava tumor thrombus: a retrospective study.肾细胞癌合并下腔静脉瘤栓患者下腔静脉壁侵犯评估的影像学预测因素:一项回顾性研究
Chin Med J (Engl). 2020 Sep 5;133(17):2078-2083. doi: 10.1097/CM9.0000000000000828.
4
Surgical complexity and prognostic outcome of small volume renal cell carcinoma with high-level venous tumor thrombus and large volume renal cell carcinoma with low-level thrombus.小体积伴高水平静脉瘤栓肾细胞癌和大体积伴低水平瘤栓肾细胞癌的手术复杂性和预后结局。
Chin Med J (Engl). 2019 Aug 5;132(15):1780-1787. doi: 10.1097/CM9.0000000000000352.
5
The influence of venous tumor thrombus combined with bland thrombus on the surgical treatment and prognosis of renal cell carcinoma patients.静脉瘤栓合并癌栓对肾癌患者手术治疗及预后的影响。
Cancer Med. 2020 Aug;9(16):5860-5868. doi: 10.1002/cam4.3264. Epub 2020 Jul 6.
6
A modified surgical technique of shortening renal ischemia time in left renal cancer patients with Mayo level II-IV tumor thrombus.一种用于缩短梅奥分级II-IV级肿瘤血栓的左肾癌患者肾缺血时间的改良手术技术。
BMC Surg. 2020 Jun 5;20(1):120. doi: 10.1186/s12893-020-00769-w.
7
Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center.外科治疗在肾细胞癌患者中具有预后获益,这些患者的血栓延伸至肾静脉和下腔静脉:单中心 17 年经验。
BMC Urol. 2013 Oct 14;13:47. doi: 10.1186/1471-2490-13-47.
8
Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.细胞减灭性肾切除术治疗伴有静脉瘤栓的肾细胞癌。
J Urol. 2017 Aug;198(2):281-288. doi: 10.1016/j.juro.2017.03.011. Epub 2017 Mar 6.
9
Venous tumor thrombus consistency: is it a prognostic factor of survival for patients with renal cell carcinoma?静脉肿瘤血栓的质地:它是肾细胞癌患者生存的预后因素吗?
Updates Surg. 2023 Oct;75(7):2033-2038. doi: 10.1007/s13304-023-01544-1. Epub 2023 Jul 3.
10
Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience.中国肾细胞癌伴静脉瘤栓延伸患者的临床和肿瘤学结局:单中心经验
World J Surg Oncol. 2015 Feb 4;13:14. doi: 10.1186/s12957-015-0448-2.

引用本文的文献

1
Resection of extensive segments of inferior vena cava without reconstruction in the treatment of renal carcinoma with inferior vena cava tumor thrombus: A case report.广泛下腔静脉节段切除术而无需重建治疗下腔静脉肿瘤栓子的肾癌:一例报告。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241272549. doi: 10.1177/03946320241272549.
2
Influence of tumor thrombus morphology on the surgical complexity in renal cell carcinoma with inferior vena cava tumor thrombus: a single-center, large-sample study from China.中国单中心大样本研究:肿瘤栓形态对肾细胞癌伴下腔静脉瘤栓手术复杂性的影响。
World J Urol. 2024 Jul 29;42(1):454. doi: 10.1007/s00345-024-05170-3.
3

本文引用的文献

1
Completely laparoscopic versus open radical nephrectomy and infrahepatic tumor thrombectomy: Comparison of surgical complexity and prognosis.完全腹腔镜与开放根治性肾切除术联合肝下肿瘤血栓切除术:手术复杂性和预后的比较。
Asian J Surg. 2021 Apr;44(4):641-648. doi: 10.1016/j.asjsur.2020.12.003. Epub 2020 Dec 17.
2
A Predictive Model for Tumor Invasion of the Inferior Vena Cava Wall Using Multimodal Imaging in Patients with Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus.基于多模态影像的肾细胞癌合并下腔静脉瘤栓患者下腔静脉壁肿瘤侵犯预测模型。
Biomed Res Int. 2020 Oct 6;2020:9530618. doi: 10.1155/2020/9530618. eCollection 2020.
3
Stoma associated complications after diverting loop ileostomy, end ileostomy or split stoma formation after right sided colectomy-a retrospective cohort study (StoComSplit Analysis).
右半结肠切除术后预防性回肠造口、末端回肠造口或双口造口术相关并发症的回顾性队列研究(StoComSplit 分析)。
Tech Coloproctol. 2024 Jun 12;28(1):68. doi: 10.1007/s10151-024-02945-z.
4
The Role of Anticoagulation in Tumor Thrombus Associated with Renal Cell Carcinoma: A Literature Review.抗凝在肾细胞癌相关肿瘤血栓形成中的作用:文献综述
Cancers (Basel). 2023 Nov 13;15(22):5382. doi: 10.3390/cancers15225382.
5
Efficacy and safety analysis of TACE + sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: a retrospective study.TACE+舒尼替尼与舒尼替尼治疗不可切除的晚期肾细胞癌的疗效和安全性分析:一项回顾性研究。
BMC Cancer. 2023 Mar 24;23(1):270. doi: 10.1186/s12885-023-10754-0.
6
Clinical Characteristics and Surgical Outcomes of Carotid Body Tumors: Data from the Carotid Paraganglioma Cooperative International Registry (CAPACITY) Group.颈动脉体肿瘤的临床特征和手术结果:来自颈动脉体副神经节瘤合作国际注册中心(CAPACITY)的数据。
World J Surg. 2022 Oct;46(10):2507-2514. doi: 10.1007/s00268-022-06663-1. Epub 2022 Jul 24.
7
The focus clinical research in intrahepatic cholangiocarcinoma.肝内胆管细胞癌的重点临床研究。
Eur J Med Res. 2022 Jul 11;27(1):116. doi: 10.1186/s40001-022-00741-9.
The influence of venous tumor thrombus combined with bland thrombus on the surgical treatment and prognosis of renal cell carcinoma patients.
静脉瘤栓合并癌栓对肾癌患者手术治疗及预后的影响。
Cancer Med. 2020 Aug;9(16):5860-5868. doi: 10.1002/cam4.3264. Epub 2020 Jul 6.
4
Progression-free survival in oncology: Caveat emptor!肿瘤学中的无进展生存期:谨慎购买!
Basic Clin Pharmacol Toxicol. 2019 Mar;124(3):240-244. doi: 10.1111/bcpt.13168. Epub 2018 Dec 12.
5
Renal Cell Carcinoma with Venous Thrombus: Should Surgery Be Offered When Metastasis Is Present at Diagnosis?伴有静脉血栓的肾细胞癌:诊断时存在转移时是否应进行手术?
Urol Int. 2018;101(4):387-390. doi: 10.1159/000493510. Epub 2018 Oct 12.
6
A systematic review and meta-analysis of clinicopathologic factors linked to oncologic outcomes for renal cell carcinoma with tumor thrombus treated by radical nephrectomy with thrombectomy.根治性肾切除术联合血栓切除术治疗肾细胞癌伴肿瘤血栓的临床病理因素与肿瘤学结局关系的系统评价和荟萃分析。
Cancer Treat Rev. 2018 Sep;69:112-120. doi: 10.1016/j.ctrv.2018.06.014. Epub 2018 Jun 21.
7
Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium.体外循环和深低温停循环下肾细胞癌侵犯膈上下腔静脉和/或右心房行肾切除术和腔静脉血栓切除术的围手术期和肿瘤学结果。
Eur Urol. 2018 May;73(5):793-799. doi: 10.1016/j.eururo.2017.08.019. Epub 2017 Sep 13.
8
Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium.国际肾细胞癌-静脉血栓形成联盟多机构分析:肾细胞癌合并肿瘤栓子患者肾静脉或下腔静脉镜下壁侵犯对癌症特异性生存的影响。
Eur Urol Focus. 2018 Apr;4(3):435-441. doi: 10.1016/j.euf.2017.01.009. Epub 2017 Feb 9.
9
Robotic versus Open Level I-II Inferior Vena Cava Thrombectomy: A Matched Group Comparative Analysis.机器人与开放一级-II 下腔静脉血栓切除术:匹配组比较分析。
J Urol. 2017 Dec;198(6):1241-1246. doi: 10.1016/j.juro.2017.06.094. Epub 2017 Jul 8.
10
Radiologic Assessment of Native Renal Vasculature: A Multimodality Review.天然肾血管系统的放射学评估:多模态综述
Radiographics. 2017 Jan-Feb;37(1):136-156. doi: 10.1148/rg.2017160060.